Publication Registration: |
Wednesday, September 14, 2005 |
Goods and Services Information
|
Description:
|
(1) - Pharmaceutical preparations for the prevention and/or treatment of disorders of the central nervous system, namely central nervous system infections, brain diseases, central nervous system movement disorders, spinal cord diseases, ocular motility disorders, psychiatric diseases, namely mood, anxiety and cognitive disorders, migraines and pain; pharmaceutical preparations for the prevention and/or treatment of immunologic diseases, namely autoimmune diseases and immunologic deficiency syndromes; pharmaceutical preparations for the prevention and/or treatment of disorders of the cardio-vascular system; pharmaceutical preparations for the prevention and/or treatment of disorders of the respiratory system; pharmaceutical preparations for the treatment of musculo-skeletal disorders, namely connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains and cartilage injuries; pharmaceutical preparations for the treatment of genitourinary diseases, namely urological diseases, infertility, sexually transmitted diseases and inflammatory pelvic diseases; sex hormones; anti-inflammatories; pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases and tissue and skin repair preparations; pharmaceutical preparations for use in oncology, in ophthalmology, for use in the gastroenterological area and the prevention and treatment of ocular disorders or diseases.
(2) - Pharmaceutical preparations for the prevention and/or treatment of disorders of the central nervous system, namely central nervous system infections, brain diseases, central nervous system movement disorders, spinal cord diseases, ocular motility disorders, psychiatric diseases, namely mood, anxiety and cognitive disorders, migraines and pain; pharmaceutical preparations for the prevention and/or treatment of immunologic diseases, namely autoimmune diseases and immunologic deficiency syndromes; pharmaceutical preparations for the prevention and/or treatment of disorders of the cardio-vascular system; pharmaceutical preparations for the prevention and/or treatment of disorders of the respiratory system; pharmaceutical preparations for the treatment of musculo-skeletal disorders, namely connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains and cartilage injuries; pharmaceutical preparations for the treatment of genitourinary diseases, namely urological diseases, infertility, sexually transmitted diseases and inflammatory pelvic diseases; sex hormones; anti-inflammatories; pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases and tissue and skin repair preparations; pharmaceutical preparations for use in oncology, in ophthalmology, for use in the gastroenterological area and the prevention and treatment of ocular disorders or diseases.
(3) - Pharmaceutical preparations for the prevention and/or treatment of disorders of the central nervous system, namely central nervous system infections, brain diseases, central nervous system movement disorders, spinal cord diseases, ocular motility disorders, psychiatric diseases, namely mood, anxiety and cognitive disorders, migraines and pain; pharmaceutical preparations for the prevention and/or treatment of immunologic diseases, namely autoimmune diseases and immunologic deficiency syndromes; pharmaceutical preparations for the prevention and/or treatment of disorders of the cardio-vascular system; pharmaceutical preparations for the prevention and/or treatment of disorders of the respiratory system; pharmaceutical preparations for the treatment of musculo-skeletal disorders, namely
|